Merck invests in animal health tracking and monitoring with $2.4 billion acquisition of Antelliq

December 18, 2018
Emerging Ecosystems in Agrifood and Health More...
by Joshua Haslun
Very important

The acquisition comes after other players in the livestock health and production industry (e.g., Cargill) have strategically invested in animal health monitoring and tracking technology. Antelliq develops a wide array of animal health monitoring solutions for livestock, pet care, and aquaculture. Antelliq will be a wholly owned and separately operated subsidiary within Merck's animal health business unit. Antelliq provides Merck with a large client pool, which previously generated $360 million in annual revenue (while amassing $1.3 billion in debt). Even so, Antelliq's technologies complement Merck's health products, and therefore, clients should consider this a savvy move by Merck to strengthen its position in the animal health sector.

For the original news article, click here .

Further Reading

Bill Gates invests in Indonesian online healthcare platform Halodoc

News Commentary | July 25, 2019

Halodoc has secured $65 million in a Series B round from strategic investors that also include insurers Allianz X and Prudential. What's interesting is that this also marks the Bill & Melinda Gates Foundation's first equity investment in an online healthcare platform. While Bill Gates has ... Not part of subscription

Elanco acquires Bayer Animal Health for $7.6 billion to close in on animal health leader Zoetis

News Commentary | August 21, 2019

Amid costly lawsuits pertaining to glyphosate liability, Bayer is selling its animal health business to Elanco Animal Health for $5.3 billion in cash and $2.3 billion in Elanco shares. This event comes about a year after Eli Lilly's divestiture of Elanco and its initial public offering in September ... Not part of subscription

Urinalysis company aims to be No. 1 through acquisition of competitor Inui Health

News Commentary | June 30, 2020

In light of COVID‑19, remote testing has seen a surge in interest, as routine testing can be outsourced to the home. By acquiring Inui Health, is acquiring its biggest competitor in its most lucrative market, the U.S. Additionally, prior to its growth as a urinalysis company, Inui was ... Not part of subscription